These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6207882)

  • 1. Yellow fever vaccination in the Americas.
    Bull Pan Am Health Organ; 1984; 18(2):188-92. PubMed ID: 6207882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever in the Americas.
    Bull Pan Am Health Organ; 1985; 19(2):209-12. PubMed ID: 4052698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever as an endemic/epidemic disease and priorities for vaccination.
    Monath TP
    Bull Soc Pathol Exot; 2006 Dec; 99(5):341-7. PubMed ID: 17253051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
    Tomori O
    Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever vaccination: how much is enough?
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Yellow fever epidemiology in Brazil].
    Mondet B
    Bull Soc Pathol Exot; 2001 Aug; 94(3):260-7. PubMed ID: 11681224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of yellow fever in persons traveling to the tropics.
    Monath TP; Cetron MS
    Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to 17D yellow fever vaccine in Ghanaian infants.
    Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA; Odoom JK; Nkrumah FK
    Bull World Health Organ; 2001; 79(11):1056-9. PubMed ID: 11731813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of the Arilvax; yellow fever vaccine.
    Barrett AD
    Expert Rev Vaccines; 2004 Aug; 3(4):413-20. PubMed ID: 15270646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic of jungle yellow fever in Brazil, 2000: implications of climatic alterations in disease spread.
    Vasconcelos PF; Costa ZG; Travassos Da Rosa ES; Luna E; Rodrigues SG; Barros VL; Dias JP; Monteiro HA; Oliva OF; Vasconcelos HB; Oliveira RC; Sousa MR; Barbosa Da Silva J; Cruz AC; Martins EC; Travassos Da Rosa JF
    J Med Virol; 2001 Nov; 65(3):598-604. PubMed ID: 11596099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever, Rift Valley fever].
    Digoutte JP
    Bull Soc Pathol Exot; 1999 Dec; 92(5):343-8. PubMed ID: 10690474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.